The largest real-world prospective outcome study to date, including 5,000 consecutive heart failure (HF) patients with secondary mitral regurgitation (SMR), reinforces the safety and effectiveness of transcutaneous edge-to-edge repair (TEER) using the MitraClip System (Abbott).